Exogenous Cushing syndrome from an unexpected source of systemic steroids

Publication Date

2018

Journal Title

Pediatr Dermatol

Abstract

© 2018 Wiley Periodicals, Inc. A 12-year-old Hispanic boy with chronic atopic dermatitis and cushingoid features presented to our institution. He was being treated with an unknown quantity of oral prednisolone 15 mg/5 mL, equivalent to 70 mg/m2/d of oral prednisone, purchased over the counter in El Salvador. Systemic corticosteroids are not recommended for chronic therapy of atopic dermatitis because of their significant adverse effects. Foreign-sourced pharmaceuticals account for almost half of the drugs consumed in the United States, which means that, to protect our patients, medical providers must inquire about and report unsafe medications deemed legal outside the United States to the Food and Drug Administration.

Volume Number

35

Issue Number

3

Pages

e196 - e197

Document Type

Article

Status

Faculty

Facility

School of Medicine

Primary Department

Emergency Medicine

PMID

29574945

DOI

10.1111/pde.13456

For the public and Northwell Health campuses

Share

COinS